Spanish Red Biotech Pipeline
< Back
Drugs: Multinational Subsidiaries
Home
Toggle navigation
Pipeline
DRUGS: MULTINATIONAL SUBSIDIARIES
DRUGS: NATIONAL COMPANIES
RESEARCH PLATFORMS
DIAGNOSTICS AND PERSONALIZED MEDICINE
OTHER TECHNOLOGIES
Search
Charts
DRUGS: MULTINATIONAL SUBSIDIARIES
DRUGS: NATIONAL COMPANIES
DIAGNOSTICS AND PERSONALIZED MEDICINE
OTHER TECHNOLOGIES
Green pipeline
White pipeline
Spanish Red Biotech Pipeline
/
Pipeline
/
Drugs: Multinational Subsidiaries
Merck KGaA
M1774 (ATR inhibitor)
Type:
Biodrugs/ Drugs
Therapeutic area:
Cancer
Indication:
DDRiver Solid Tumors 301. ATR inhibitor monotherapy and in combination with niraparib
Phase:
1
Phase I in Spain